M2GEN Market Share Analysis for May 2026

aster insights is the leading provider of scientific and clinical intelligence for oncology product discovery and development.

Industry: N/A

Domainm2gen.com

Year Founded2006

Employees51 - 200

Annual Revenue$15M - $25M

M2GEN

M2GEN (including company regionals)

m2gen.com

See more website traffic and engagement information

M2GEN Revenue up to May 2026 is 15M - 25M

revenue generated by M2GEN top domains

M2GEN top domains revenue over 3 years

Revenue for M2GEN top domains

m2gen.com15M - 25M

See more with Sales Intelligence

Total visits to M2GEN's top domains

Understand M2GEN market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in M2GEN's top domains

Analyze M2GEN engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on M2GEN's top domains

See how M2GEN keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

M2GEN top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by M2GEN

These are the website technologies, by industry, used by M2GEN top domains

Advertising (5)

DoubleClick

Social (4)

Instagram

Content Management System (2)

Web Dot Com

Conversion & Analytics (2)

Google Analytics

More Technologies

9

See all

News & Signals from M2GEN

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAbsci, Corp partnered with M2Gen on Apr 1st '23.Drug development firm Absci said Tuesday that it is partnering with cancer-focused bioinformatics company M2Gen to accelerate the discovery process for new cancer biologics.

NewsM2Gen partnered with Zephyr AI, Inc. on Feb 16th '23.Cancer-focused bioinformatics firm M2Gen said Thursday that it has formed a strategic partnership with artificial intelligence startup Zephyr AI that the firms hope will advance target and drug discovery for precision oncology treatments.

NewsM2Gen integrates with Zephyr AI, Inc..M2GEN’s data will be integrated into Zephyr’s trademark Vulnerability Network™ Method, which leverages groundbreaking algorithms to classify tumors and reveal new targets for drug discovery, label expansion, and precision care.